BD
Bio Design Lab develops biopharmaceuticals utilizing synthetic biology and systems-level genetic designs. The company focuses on advancing retroviral and lentiviral vector platforms as foundational technologies. These platforms support the development of novel cell and gene therapies.
Updated 2 months ago
Funding
Funding not disclosed
TP
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops biopharmaceuticals utilizing systems-level genetic and genomic design strategies to create gene, cell, and immuno-therapies. Their approach enables healthcare organizations to expedite the development of potent treatments for various diseases.